Lead sponsor
Seoul National University Hospital
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
2
Trials led
0
Active
80
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Early Phase 1
1
Not applicable
1
Trials by status
Completed
1
Unknown
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot StudyBMI ≤30Early Ph 1Unknown50
Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the BrainBMI ≤23not applicableCompleted30